Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases.

Jui-Ming LiuCheng-Ping YuHeng-Chang ChuangChun-Te WuRen-Jun Hsu

Published in: Prostate cancer and prostatic diseases (2019)

We observed that ADT use in patients with PCa was associated with a decreased risk of autoimmune diseases. These novel findings provide a potential role for androgen deprivation therapy in the modification of inflammation and autoimmunity in Asian patients with prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
oxidative stress
stem cells
bone marrow
mesenchymal stem cells
cell therapy
celiac disease
smoking cessation